Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007)
as amended
made under section 93 of the
National Health Act 1953
This compilation was prepared on 1 October 2009
taking into account amendments up to PB 91 of 2009
Prepared by the Office of Legislative Drafting and Publishing,
Attorney-General’s Department, Canberra
Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007)
Commencement [see Note 1]
1. This instrument commences on 1 August 2007.
Repeal
2. Determination No. PB 35 of 2006 under section 93 of the National Health Act 1953, made on 26 July 2006 with effect from 1 August 2006, is repealed.
Pharmaceutical benefits
3. A pharmaceutical benefit which has a listed drug in a form mentioned in the Schedule is a pharmaceutical benefit which a medical practitioner is authorised to supply.
Maximum quantity or number of units
4. The maximum quantity or number of units of a pharmaceutical benefit which may be obtained by a medical practitioner in any period of one month is the quantity or number of units mentioned in the Schedule under the column “maximum quantity” for the listed drug in the form mentioned less the quantity or number of units of the pharmaceutical benefit previously obtained in accordance with section 93 of the Act and still in the possession of the medical practitioner.
Adrenaline | Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | 5 |
Atropine | Injection containing atropine sulfate 600 micrograms in 1 mL | 10 |
Benztropine | Injection containing benztropine mesylate 2 mg in 2 mL | 5 |
Benzylpenicillin | Powder for injection 600 mg (as sodium) | 10 |
OR |
|
|
Procaine Penicillin | Injection 1.5 g in disposable syringe | 5 |
Benzylpenicillin | Powder for injection 3 g (as sodium) | 1 |
Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | 10 |
OR |
|
|
Haloperidol | Injection 5 mg in 1 mL | 10 |
Clonazepam | Oral liquid 2.5 mg per mL, 10 mL | 1 |
Dexamethasone | Injection containing dexamethasone sodium phosphate equivalent to 4 mg dexamethasone phosphate in 1 mL | 5 |
OR |
|
|
Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | 2 |
OR |
|
|
Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | 1 |
Diazepam | Injection 10 mg in 2 mL | 5 |
Dihydroergotamine | Injection containing dihydroergotamine mesylate 1 mg in 1 mL | 5 |
Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre-filled syringe | 20 |
Frusemide | Injection 20 mg in 2 mL | 5 |
Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | 1 |
Glyceryl Trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | 1 |
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | 5 |
Lignocaine | Injection containing lignocaine hydrochloride 100 mg in 5 mL | 5 |
Metoclopramide | Injection containing metoclopramide hydrochloride 10 mg in 2 mL | 10 |
OR |
|
|
Prochlorperazine | Injection containing prochlorperazine mesylate 12.5 mg in 1 mL | 10 |
Morphine | Injection containing morphine sulfate 15 mg in 1 mL | 5 |
OR |
|
|
Morphine | Injection containing morphine sulfate 30 mg in 1 mL | 5 |
Naloxone | Injection containing naloxone hydrochloride 2 mg in 5 mL disposable injection set | 2 |
Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | 10 |
Salbutamol | Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation) | 1 |
OR |
|
|
Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | 1 |
Salbutamol | Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | 1 |
Terbutaline | Injection containing terbutaline sulfate 500 micrograms in 1mL | 5 |
Tramadol | Injection containing tramadol hydrochloride 100 mg in 2 mL | 5 |
Verapamil | Injection containing verapamil hydrochloride 5 mg in 2 mL | 5 |
Notes to the Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007)
Note 1
The Pharmaceutical benefits supplied by medical practitioners (PB 57 of 2007) (in force under section 93 of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.
Table of Instruments
Title | Date of FRLI Registration | Date of | Application, saving or |
PB 57 of 2007 | 31 July 2007 (see F2007L02403) | 1 Aug 2007 |
|
PB 72 of 2007 | 12 Sept 2007 (see F2007L03623) | 1 Oct 2007 | — |
PB 63 of 2008 | 11 June 2008 (see F2008L02053) | 1 July 2008 | — |
PB 91 of 2009 | 17 Sept 2009 (see F2009L03541) | 1 Oct 2009 | — |
Table of Amendments
ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted | |
Provision affected | How affected |
The Schedule |
|
The Schedule.......... | am. PB 72 of 2007; PB 63 of 2008; PB 91 of 2009 |